Solid formulations containing omega-3 and resveratrol
A technology of resveratrol and omega, applied in medical preparations containing active ingredients, medical preparations with non-active ingredients, anti-inflammatory agents, etc., can solve problems such as ineffective acquisition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0051] example
[0052] Materials and methods:
[0053] For the purposes of the present invention, the following materials were used:
[0054] Omega-3 polyunsaturated fatty acids (n-3PUFA) are mixtures of ethyl esters of polyunsaturated fatty acids, which are produced by Pronova, Norway, with EPA and DHA content greater than 85%, and EPA / DHA ratio between 0.9 and 1.5 between;
[0055] Resveratrol was provided by Royalmount Pharmaceuticals (Montreal, Canada);
[0056] The magnesium aluminum silicate used is also known It was provided by Fuji Chemical Industry Co., Ltd, Japan;
[0057] · Tocopherol was provided by Sigma-Aldrich S.r.l (Milan, Italy);
[0058] · Syloid XDP was provided by Grace Performance Chemicals (Worms, Germany);
[0059] Coenzyme Q10 was provided by Sigma-Aldrich S.r.l (Milan, Italy);
[0060]· Ascorbyl palmitate was provided by Sigma-Aldrich S.r.l (Milan, Italy);
[0061] Lipoic acid was provided by Sigma-Aldrich S.r.l (Milan, Italy);
[0062] · A...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


